Barinthus Biotherapeutics plc. financial data

Symbol
BRNS on Nasdaq
Location
Unit 6 10, Zeus Building, Rutherford Avenue, Harwell, Didcot, United Kingdom
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 849 % -16.1%
Debt-to-equity 22.3 % +32.6%
Return On Equity -54.7 % -52.5%
Return On Assets -44.8 % -45.7%
Operating Margin -454 % +95.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.7M shares +3.31%
Common Stock, Shares, Outstanding 40.3M shares +2.97%
Entity Public Float 31.1M USD -60.8%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 40.3M shares +3.34%
Weighted Average Number of Shares Outstanding, Diluted 40.3M shares +3.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15M USD +1766%
Research and Development Expense 35.7M USD -19.4%
General and Administrative Expense 44.5M USD +60.2%
Operating Income (Loss) -76.7M USD -7.58%
Nonoperating Income (Expense) 7.14M USD +19.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -69.6M USD -6.46%
Income Tax Expense (Benefit) -47K USD +96.8%
Net Income (Loss) Attributable to Parent -69.4M USD -8.84%
Earnings Per Share, Basic -1 USD/shares -5.49%
Earnings Per Share, Diluted -1 USD/shares -5.49%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 172K USD -99%
Other Assets, Current 854K USD +36.4%
Assets, Current 100M USD -23.9%
Property, Plant and Equipment, Net 4.51M USD -58.8%
Operating Lease, Right-of-Use Asset 3.32M USD -54.4%
Intangible Assets, Net (Excluding Goodwill) 20.4M USD -13.4%
Goodwill 0 USD -100%
Assets 130M USD -30.6%
Accounts Payable, Current 1.8M USD -29.6%
Liabilities, Current 12.7M USD -18.4%
Deferred Income Tax Liabilities, Net 391K USD
Operating Lease, Liability, Noncurrent 9.95M USD -6.59%
Other Liabilities, Noncurrent 1.47M USD +9.72%
Liabilities 27.1M USD -9.61%
Retained Earnings (Accumulated Deficit) -278M USD -33.2%
Stockholders' Equity Attributable to Parent 102M USD -34.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 102M USD -34.6%
Liabilities and Equity 130M USD -30.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.9M USD -26.1%
Net Cash Provided by (Used in) Financing Activities 2M USD +298%
Net Cash Provided by (Used in) Investing Activities -5K USD +98.4%
Common Stock, Shares Authorized 40.3M shares +2.97%
Common Stock, Shares, Issued 40.3M shares +2.97%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.8M USD +2.46%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 87.8M USD -25.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 30.8M USD +23%
Deferred Tax Assets, Gross 40.6M USD +12.2%
Operating Lease, Liability 12M USD -4.63%
Depreciation 3.7M USD +37%
Payments to Acquire Property, Plant, and Equipment 5K USD -98.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57.6M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid 15.5M USD -7.9%
Property, Plant and Equipment, Gross 16.8M USD +8.28%
Operating Lease, Liability, Current 2.04M USD +6.26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.07M USD +6.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.05M USD +6.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -22K USD +40.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.48M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.1M USD +6.12%
Deferred Tax Assets, Operating Loss Carryforwards 26M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.13M USD +6.09%
Operating Lease, Payments 478K USD +38.2%
Additional Paid in Capital 394M USD +0.87%
Amortization of Intangible Assets 3.2M USD 0%
Depreciation, Depletion and Amortization 2.03M USD +42.2%
Deferred Tax Assets, Net of Valuation Allowance 9.81M USD -12.2%
Share-based Payment Arrangement, Expense 2.09M USD -42.9%
Interest Expense 12K USD